These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24935691)

  • 1. Adverse Drug Reactions to Antiretroviral Therapy in HIV-Infected Patients at the Largest Public Hospital in Nicaragua.
    Lorío M; Colasanti J; Moreira S; Gutierrez G; Quant C
    J Int Assoc Provid AIDS Care; 2014; 13(5):466-70. PubMed ID: 24935691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study.
    Mehta U; Durrheim DN; Blockman M; Kredo T; Gounden R; Barnes KI
    Br J Clin Pharmacol; 2008 Mar; 65(3):396-406. PubMed ID: 18070223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.
    Eluwa GI; Badru T; Agu KA; Akpoigbe KJ; Chabikuli O; Hamelmann C
    BMC Clin Pharmacol; 2012 Feb; 12():7. PubMed ID: 22369677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature and prevalence of adverse drug reaction of antiretroviral medications in Halibet National Referral Hospital: a retrospective study.
    Hagos L; Fessehaye S; Anand IS
    BMC Pharmacol Toxicol; 2019 May; 20(1):24. PubMed ID: 31060603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Adverse Drug Reactions among Pediatric Patients on Antiretroviral Therapy in Selected Hospitals in Eastern Ethiopia: 8-Year Retrospective Cross-Sectional Study.
    Abdela J; Assefa A; Shamele S
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218823208. PubMed ID: 30798673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual Costs Incurred in Managing Adverse Drug Reactions Attributable to Fixed-Dose Combination Highly Active Antiretroviral Therapy in an Outpatient Antiretroviral Clinic in Gauteng: A Budget Impact Analysis.
    Chikeya G; Oosthuizen F; Bangalee V
    Value Health Reg Issues; 2021 Sep; 25():142-149. PubMed ID: 34130039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions associated with first-line regimens in patient initiating antiretroviral therapy.
    Mendes JC; Bonolo PF; Ceccato MDGB; Costa JO; Reis AMM; Dos Santos H; Silveira MR
    Eur J Clin Pharmacol; 2018 Aug; 74(8):1077-1088. PubMed ID: 29740676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral Therapy-associated Adverse Drug Reactions and their Effects on Virologic Failure- A Retrospective Cohort Study in Nigeria.
    Abah IO; Ncube NBQ; Bradley HA; AgbaJi OO; Kanki P
    Curr HIV Res; 2018; 16(6):436-446. PubMed ID: 30767743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting and recording of adverse drug reactions of highly active antiretroviral therapy by HIV infected patients and healthcare professionals respectively in the Ethekwini Metropolitan of Kwa-Zulu Natal, South Africa: a cross-sectional and retrospective comparative study.
    Zondi SL; Naidoo P
    Pan Afr Med J; 2022; 42():218. PubMed ID: 36845236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reaction monitoring in patients on antiretroviral therapy in a tertiary care hospital in Eastern India.
    Mukherjee S; Era N; Saha B; Tripathi SK
    Indian J Pharmacol; 2017; 49(3):223-228. PubMed ID: 29033481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study From Ethiopia.
    Bezabhe WM; Bereznicki LR; Chalmers L; Gee P; Kassie DM; Bimirew MA; Peterson GM
    Drug Saf; 2015 Jul; 38(7):629-39. PubMed ID: 26008986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of Adverse Drug Reaction (ADR) among adult HIV positive patients on anti-retroviral treatment in Arba Minch town public health facilities, southern Ethiopia: A retrospective cohort study, 2020.
    Sherfa A; Haile D; Yihune M; Sako S
    PLoS One; 2021; 16(5):e0251763. PubMed ID: 34043687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study.
    Namme Luma H; Doualla MS; Choukem SP; Temfack E; Ashuntantang G; Achu Joko H; Koulla-Shiro S
    Pan Afr Med J; 2012; 12():87. PubMed ID: 23077708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-retro viral therapy adverse drug reaction and associated factors among human immuno deficiency virus infected adult patients at Nigist Eleni Mohammed Memorial hospital, South Ethiopia.
    Tamirat T; Woldemichael K; Tewelde T; Laelago T
    Afr Health Sci; 2020 Jun; 20(2):560-567. PubMed ID: 33163017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India.
    Anwikar SR; Bandekar MS; Smrati B; Pazare AP; Tatke PA; Kshirsagar NA
    Int J Risk Saf Med; 2011; 23(3):163-9. PubMed ID: 22020396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional study.
    Tadesse WT; Mekonnen AB; Tesfaye WH; Tadesse YT
    BMC Pharmacol Toxicol; 2014 Jun; 15():32. PubMed ID: 24957052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine data underestimates the incidence of first-line antiretroviral drug discontinuations due to adverse drug reactions: Observational study in two South African cohorts.
    de Waal R; Cohen K; Boulle A; Fox MP; Maartens G; Igumbor EU; Davies MA
    PLoS One; 2018; 13(9):e0203530. PubMed ID: 30183766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Drug Reactions Causing Admission to Medical Wards: A Cross-Sectional Survey at 4 Hospitals in South Africa.
    Mouton JP; Njuguna C; Kramer N; Stewart A; Mehta U; Blockman M; Fortuin-De Smidt M; De Waal R; Parrish AG; Wilson DPK; Igumbor EU; Aynalem G; Dheda M; Maartens G; Cohen K
    Medicine (Baltimore); 2016 May; 95(19):e3437. PubMed ID: 27175644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults.
    Cohen C; Wohl D; Arribas JR; Henry K; Van Lunzen J; Bloch M; Towner W; Wilkins E; Ebrahimi R; Porter D; White K; Walker I; Chuck S; De-Oertel S; Fralich T
    AIDS; 2014 Apr; 28(7):989-97. PubMed ID: 24508782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmation of factors that influence antiretroviral regimen change and the subsequent patient outcomes at a Regional Hospital in rural KwaZulu-Natal.
    Soorju V; Naidoo P
    Afr J Prim Health Care Fam Med; 2016 Oct; 8(1):e1-e6. PubMed ID: 28155312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.